Bal Pharma Ltd.
| BSE: 524824 | Sector: Health care |
| NSE: BALPHARMA | ISIN Code: INE083D01012 |
| BSE 14:42 | 29 Jun | 96.30 |
-2.25 (-2.28%) |
OPEN
96.75 |
HIGH
97.05 |
LOW
96.20 |
| NSE 14:33 | 29 Jun | 96.90 |
-1.80 (-1.82%) |
OPEN
97.80 |
HIGH
97.90 |
LOW
95.25 |
| OPEN | 96.75 |
| PREVIOUS CLOSE | 98.55 |
| VOLUME | 2581 |
| 52-Week high | 148.50 |
| 52-Week low | 87.50 |
| P/E | 17.48 |
| Mkt Cap.(Rs cr) | 150 |
| Buy Price | 96.45 |
| Buy Qty | 10.00 |
| Sell Price | 97.25 |
| Sell Qty | 1.00 |
Bal Pharma Ltd. (BALPHARMA) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 515.30 | -6.00 | -1.15 | 15823.68 |
| Cipla | 930.25 | -14.45 | -1.53 | 13900.58 |
| Dr Reddy's Labs | 4354.45 | -20.20 | -0.46 | 13349.10 |
| Sun Pharma.Inds. | 832.00 | 4.05 | 0.49 | 12803.21 |
| Lupin | 622.35 | -11.20 | -1.77 | 11055.93 |
| Apollo Hospitals | 3761.50 | -77.20 | -2.01 | 9153.00 |
| Zydus Lifesci. | 355.95 | -1.80 | -0.50 | 7790.40 |
| Glenmark Pharma. | 388.15 | 0.70 | 0.18 | 7567.93 |
| Alkem Lab | 2964.30 | -26.00 | -0.87 | 7219.68 |
| Divi's Lab. | 3583.00 | -30.95 | -0.86 | 6798.61 |
| Torrent Pharma. | 2855.00 | -27.15 | -0.94 | 6450.83 |
| Ipca Labs. | 890.10 | -12.10 | -1.34 | 5114.11 |
| Alembic Pharma | 730.20 | -8.05 | -1.09 | 5051.44 |
| Laurus Labs | 465.30 | -3.40 | -0.73 | 4707.04 |
| Abbott India | 19005.00 | 878.90 | 4.85 | 4310.02 |
| Gland Pharma | 2655.60 | 7.95 | 0.30 | 3462.88 |
| Glaxosmi. Pharma | 1494.85 | -3.70 | -0.25 | 3193.74 |
| Granules India | 276.35 | 0.95 | 0.34 | 3134.98 |
| Sanofi India | 6405.65 | -0.50 | -0.01 | 2956.60 |
| Ajanta Pharma | 1205.80 | -35.10 | -2.83 | 2718.59 |
Quick Links for Bal Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
